Paul A Mahon - Net Worth and Insider Trading

Paul A Mahon Net Worth

The estimated net worth of Paul A Mahon is at least $13 Million dollars as of 2024-12-28. Paul A Mahon is the EVP & GENERAL COUNSEL of United Therapeutics Corp and owns about 36,710 shares of United Therapeutics Corp (UTHR) stock worth over $13 Million. Details can be seen in Paul A Mahon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul A Mahon has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul A Mahon

To

Paul A Mahon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul A Mahon owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Paul A Mahon’s form 4 insider trades.

Insider Ownership Summary of Paul A Mahon

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2024-12-05 EVP & General Counsel

Paul A Mahon Latest Holdings Summary

Paul A Mahon currently owns a total of 1 stock. Paul A Mahon owns 36,710 shares of United Therapeutics Corp (UTHR) as of December 5, 2024, with a value of $13 Million.

Latest Holdings of Paul A Mahon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2024-12-05 36,710 359.96 13,214,132

Holding Weightings of Paul A Mahon


Paul A Mahon Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul A Mahon has made a total of 62 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 62 sells. The most-recent trade in United Therapeutics Corp is the sale of 7,700 shares on December 5, 2024, which brought Paul A Mahon around $3 Million.

Insider Trading History of Paul A Mahon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul A Mahon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul A Mahon Ownership Network

Ownership Network List of Paul A Mahon

No Data

Ownership Network Relation of Paul A Mahon

Insider Network Chart

Paul A Mahon Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Paul A Mahon is the EVP & General Counsel of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , CFO and Treasurer James Edgemond , and director & Chief Executive Officer Martine A Rothblatt .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Paul A Mahon made 21 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 125,900. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 133,718 shares made by James Edgemond , and a net sale of 139,700 shares made by Michael Benkowitz .

In summary, during the past 3 months, insiders sold 215,531 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 215,531 shares. During the past 18 months, 1,205,744 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,205,744 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Paul A Mahon Mailing Address

Above is the net worth, insider trading, and ownership report for Paul A Mahon. Currently GuruFocus does not have mailing address information for Paul A Mahon.

Discussions on Paul A Mahon

No discussions yet.